Dr. Cohen on CAR T-Cell Therapy for Head and Neck Cancer

Ezra Cohen, MD
Published: Thursday, Jul 20, 2017



Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses CAR T-cell therapy for patients with head and neck cancer.

Whether CAR T-cell therapy can be applied to head and neck cancer is being extensively researched, explains Cohen. A main challenge facing this space is determining the right target to see beneficial responses.

According to Cohen, stem cell antigens that are expressed exclusively on cancer cells have been shown to be good targets, however, there could be others that are still in early development.



Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses CAR T-cell therapy for patients with head and neck cancer.

Whether CAR T-cell therapy can be applied to head and neck cancer is being extensively researched, explains Cohen. A main challenge facing this space is determining the right target to see beneficial responses.

According to Cohen, stem cell antigens that are expressed exclusively on cancer cells have been shown to be good targets, however, there could be others that are still in early development.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x